Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stocks, par value $0,0001 per share
-
Shares outstanding
-
58.5M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
32.8M
-
Shares change
-
-1.02M
-
Total reported value, excl. options
-
$87.6M
-
Value change
-
-$35.8M
-
Put/Call ratio
-
0.98
-
Number of buys
-
49
-
Number of sells
-
-39
-
Price
-
$2.68
Significant Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q1 2023
106 filings reported holding BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share as of Q1 2023.
BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.8M shares
of 58.5M outstanding shares and own 56.05% of the company stock.
Largest 10 shareholders include Soleus Capital Management, L.P. (4.32M shares), ORBIMED ADVISORS LLC (3.86M shares), TANG CAPITAL MANAGEMENT LLC (3.62M shares), VANGUARD GROUP INC (1.92M shares), MORGAN STANLEY (1.88M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.59M shares), Candriam S.C.A. (1.57M shares), WASATCH ADVISORS LP (1.27M shares), Cormorant Asset Management, LP (1.18M shares), and BlackRock Inc. (984K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.